Clinical Trials
2 trialsNCT06355024 2025-07-18
Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer
Fudan University
Phase 2 Completed
NCT05809336 2023-04-12
Gut Microbial Metabolites Inosine Combined With PD-1/PD-L1 Inhibitor for Patients With Malignant Advanced Solid Tumors
Beijing Friendship Hospital
Phase 2/3 Completed